Live-talk, session 23 – insights on medicine and mental health: a perspective

March 7, 2023

Today’s program focuses on interactions between the medical and psychological worlds. Join Dr. Blevins and me as we welcome PWN contributor, marriage and family therapist, and author Linda Rio for a fascinating discussion on how pituitary disease, or any chronic disease, manifests itself mentally and emotionally. Listen as we muse on how emotional health and psychological distress can affect people’s daily lives and how they deal with their disorders.

Helping medical students learn about acromegaly

March 2, 2023

After a few virtual meetings these past years, I was back at UC Berkeley/UCSF’s joint medical program for an in-person gathering with some of the brightest and most engaged medical students on the planet. This is, without a doubt, one of my favorite things to do since founding PWN, and I look forward to it every year.

Live-talk, session 22 – Dr. Sylvia Asa discusses her groundbreaking work in endocrine pathology

February 13, 2023

This week’s Live-talk offers critical knowledge that people affected with pituitary and endocrine diseases need to know to ensure they receive proper treatment. Dr. Sylvia Asa, a pioneer in endocrine and pituitary tumor pathology, talks with Dr. Lewis Blevins about her work in the field and the reclassification of pituitary adenomas to Pituitary Neuroendocrine Tumors, or PitNets.

Articles of note for people connected to pituitary disease

January 25, 2023

Our briefing today covers articles on costs and access to therapies, sugar and artificial sweeteners, surprising news on where we are finding endocrine disruptive chemicals, an amazing discovery about a new brain layer, and a bunch of information on Cannabidiol (CBD) focusing on what we know and what we don’t. This is great info you don’t want to miss. Read on!

New name for Diabetes Insipidus (DI)

October 24, 2022

Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.